---
title: "ABBV Q2'26 Earnings: revenue estimate is 16.79B USD"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293746215.md"
description: "ABBV (AbbVie Inc.) is set to announce its Q2'26 results on July 31, before the market opens. The earnings are expected to be disclosed at 9:30 AM ET (1:30 PM UTC).For Q2'26, revenue estimate is 16.79 billion USD with EPS (earnings per share) anticipated at 3.60 USD. Learn more details at .Revenue & EPS values are provided in USDQ2'25Q3'25Q4'25Q1'26Q2'26Revenue Reported15.42 B15.78 B16.62 B15.00 B—Revenue Estimate15.03 B15.59 B16.41 B14.72 B16.79 BRevenue Surprise+2.62%+1.22%+1.25%+1.93%EPS Reported2.971.862.712.65EPS Estimate2.881.772.652.593.60EPS Surprise+3.12%+5.34%+2.15%+2.25%DisclaimerSelect reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc."
datetime: "2026-07-24T11:03:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293746215.md)
  - [en](https://longbridge.com/en/news/293746215.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293746215.md)
---

# ABBV Q2'26 Earnings: revenue estimate is 16.79B USD

ABBV (AbbVie Inc.) is set to announce its Q2'26 results on July 31, before the market opens. The earnings are expected to be disclosed at 9:30 AM ET (1:30 PM UTC).

For Q2'26, revenue estimate is 16.79 billion USD with EPS (earnings per share) anticipated at 3.60 USD. Learn more details at .

**Revenue & EPS values are provided in USD**

Q2'25

Q3'25

Q4'25

Q1'26

Q2'26

**Revenue Reported**

15.42 B

15.78 B

16.62 B

15.00 B

—

**Revenue Estimate**

15.03 B

15.59 B

16.41 B

14.72 B

16.79 B

**Revenue Surprise**

+2.62%

+1.22%

+1.25%

+1.93%

**EPS Reported**

2.97

1.86

2.71

2.65

**EPS Estimate**

2.88

1.77

2.65

2.59

3.60

**EPS Surprise**

+3.12%

+5.34%

+2.15%

+2.25%

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.

### Related Stocks

- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)

## Related News & Research

- [Should you buy AbbVie stock hand over fist before July 31?](https://longbridge.com/en/news/293985406.md)
- [AbbVie Inc Stock (ABBV) Moved Up by 3.35% on Jul 28: A Full Analysis](https://longbridge.com/en/news/294086753.md)
- [AbbVie Inc. $ABBV Shares Bought by Opal Capital LLC](https://longbridge.com/en/news/294190325.md)
- [The Bull Case For AbbVie (ABBV) Could Change Following EU Approval Of Rinvoq For Vitiligo](https://longbridge.com/en/news/294200563.md)
- [Better dividend king to buy right now: AbbVie or Johnson & Johnson?](https://longbridge.com/en/news/293843937.md)